妊娠早期暴露于哌唑嗪后的妊娠结局前瞻性评估
6/11(54.5%)受试者未报告不良结局且妊娠过程平稳,2例流产,其余9例出生体重在正常范围,不良事件与背景人群预期一致;作者认为这些数据令人安心但尚需更多数据才能判定哌唑嗪孕期安全。
要点
- 11例妊娠期哌唑嗪暴露者中6例(54.5%)妊娠过程平稳且未报告不良结局。
- 报告2例流产,其余9例出生体重均在正常范围。
- 不良事件包括产后出血、子痫前期、早产、NICU入住及剖宫产各与背景预期一致。
核心结论
- 对于这11例受试者,妊娠期暴露于哌唑嗪后的妊娠结局与未暴露妊娠的典型结局一致。
- 需要更多数据才能得出哌唑嗪在妊娠期使用安全的结论。
- 未发现高于基线的不良反应,这对可能无意中在妊娠期暴露于哌唑嗪的未来患者具有安抚作用。
研究设计与样本
- 通过病历和电话问卷收集其他暴露和妊娠结局数据。
主要发现
- 6/11(54.5%)受试者未报告任何不良结局且妊娠过程平稳。
- 报告2例流产。
- 其余9例妊娠的出生体重均在正常范围。
- 报告的不良事件包括1例产后出血、1例子痫前期、1例早产、2例NICU入住和2例剖宫产,与背景人群预期一致。
临床怎么用
- 对于无意中在妊娠早期暴露于哌唑嗪的患者,本研究的结局数据可提供参考并具有一定安抚作用。
- 临床决策时仍需结合个体情况,并告知患者目前数据有限、尚不能判定哌唑嗪孕期使用安全。
局限性
- 样本量仅11例,作者明确指出需要更多数据才能得出哌唑嗪孕期使用安全的结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Prazosin is an antihypertensive medication which can be used to help with post-traumatic stress disorder (PTSD) symptoms. Little data is currently available on its safety in pregnancy. The aim of this study was to assess the fetal and pregnancy safety associated with prazosin exposures in early pregnancy. METHODS: Subjects were 11 patients who took prazosin during pregnancy and were counselled at the FRAME clinic in London Health Sciences Centre (Ontario, Canada) between 1 January 2000 and 31 December 2021. Data on their other exposures and pregnancy outcomes were collected from medical records and through telephone questionnaires. RESULTS: It was found that 6/11 (54.5%) subjects did not report any adverse outcomes and experienced uneventful pregnancies. There were two miscarriages. Birthweights were within the normal range for the remaining nine pregnancies. Adverse events reported were consistent with background population expectation, including: one postpartum haemorrhage, one case of preeclampsia, one preterm birth, two NICU admissions, and two caesarean sections. CONCLUSIONS: For these 11 subjects, pregnancy outcomes after exposure to prazosin were consistent with typical outcomes from unexposed pregnancies. More data are needed to conclude that prazosin is safe for use in pregnant subjects. However, the lack of adverse effects above baseline is reassuring to future patients who may be unintentionally exposed to prazosin while pregnant. Therefore, this study contributes valuable data towards monitoring safety of prazosin in pregnancy.
引用
- Zitoun N, Campbell MK, Matsui D, et al. Prospective evaluation of pregnancy outcomes after gestational exposure to prazosin. Br J Clin Pharmacol. 2023. PMID: 37323115. doi:10.1111/bcp.15829
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。